Dr. Narkhede is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1720 2nd Avenue South
NP2540F North Pavilion
Birmingham, AL 35294Phone+1 205-934-2248Fax+1 949-698-6272
Education & Training
- MedStar Health/Georgetown University HospitalFellowship, Hematology and Medical Oncology, 2016 - 2019
- Cleveland Clinic FoundationResidency, Internal Medicine, 2014 - 2016
- Cleveland Clinic FoundationInternship, Internal Medicine, 2013 - 2014
- KJ Somaiya Medical CollegeClass of 2006
Certifications & Licensure
- AL State Medical License 2019 - 2024
- DC State Medical License 2016 - 2020
- OH State Medical License 2013 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy Start of enrollment: 2021 Nov 15
Roles: Principal Investigator, Contact
- Addition of Loncastuximab Tesirine to Acalbrutinib , Chronic Lymphocytic Leukemia Start of enrollment: 2023 Dec 18
Roles: Sponsor-Investigator, Principal Investigator, Contact
- PD-1, LAG-3 and TIM-3 Checkpoint Blockade in DLBCL Start of enrollment: 2024 Jun 30
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 86 citationsNCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021.Andrew D. Zelenetz, Leo I. Gordon, Julie E. Chang, Beth Christian, Jeremy S. Abramson
Journal of the National Comprehensive Cancer Network. 2021-11-01 - 19 citationsNCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023.Andrew D Zelenetz, Leo I Gordon, Jeremy S Abramson, Ranjana H Advani, Babis Andreadis
Journal of the National Comprehensive Cancer Network. 2023-11-01 - 120 citationsIncorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes.Aziz Nazha, Mayur Narkhede, Tomas Radivoyevitch, David J. Seastone, Bhumika J. Patel
Leukemia. 2016-06-17
Lectures
- External Validation and Revision of Thrombosis Lymphoma /Throly/ Score2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Lack of Prognostic Significance of Pre-Treatment Total Metabolic Tumor Volume (TMTV) in Diffuse Large B-Cell Lymphoma (DLBCL)2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Other Languages
- Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: